JPH0728905B2 - Wound cover material - Google Patents
Wound cover materialInfo
- Publication number
- JPH0728905B2 JPH0728905B2 JP61266570A JP26657086A JPH0728905B2 JP H0728905 B2 JPH0728905 B2 JP H0728905B2 JP 61266570 A JP61266570 A JP 61266570A JP 26657086 A JP26657086 A JP 26657086A JP H0728905 B2 JPH0728905 B2 JP H0728905B2
- Authority
- JP
- Japan
- Prior art keywords
- gelatin
- cover material
- wound
- wound cover
- foam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Materials For Medical Uses (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は、生体組織への密着性に優れ、長期間使用して
も創傷治癒効果が安定して維持される創傷カバー材に関
する。Description: TECHNICAL FIELD The present invention relates to a wound cover material that has excellent adhesion to living tissue and that stably maintains a wound healing effect even after long-term use.
[従来の技術およびその問題点] 熱傷などの火傷および外傷性皮膚欠損傷による創傷など
に対する治癒方法として、軟膏、リバノールガーゼなど
が既に実用化され多用されている。また、近年、凍結乾
燥豚皮、コラーゲン短繊維シート、再生セルロース、ポ
リウレタンフォーム、シリコンゴムなども用いられてい
る。しかし、これらは創傷面への密着性が劣っていた
り、密着はするものの、使用中に溶解してしまって十分
な性能発揮が維持され得ないという欠点がある。[Prior Art and its Problems] As a healing method for burns such as burns and wounds due to traumatic skin defects, ointments, ribanol gauze and the like have already been put into practical use and widely used. In recent years, freeze-dried pig skin, collagen short fiber sheet, regenerated cellulose, polyurethane foam, silicone rubber and the like have also been used. However, these have poor adhesion to the wound surface, or although they adhere to each other, they have the drawback that they dissolve during use and sufficient performance cannot be maintained.
一方、ゼラチンに止血効果があることは古くから知られ
ており、ゼラチンを基材とした創傷治癒材も多数知られ
ている。例えば、特公昭31−4644号公報および特公昭40
−9431号公報には、未変性ゼラチンまたはこれとメチル
セルロースとを混合したものを主材とし、発泡促進助剤
を添加して発泡、脱水する、海綿状止血用ゼラチンの製
造法が開示されている。しかし、ゼラチンハ血液や体液
に溶解し易いため、上記方法で得られた海綿状止血用ゼ
ラチンは、創傷面に適用したときに出血血液や体液の浸
潤を受け、溶解してしまうという欠点がある。On the other hand, it has long been known that gelatin has a hemostatic effect, and many wound healing materials based on gelatin are also known. For example, JP-B 31-4644 and JP-B 40
Japanese Patent Publication No. 9431 discloses a method for producing spongy hemostatic gelatin in which unmodified gelatin or a mixture of unmodified gelatin and methyl cellulose is used as a main material, and a foaming promoter is added to foam and dehydrate. . However, since the gelatin c is easily dissolved in blood or body fluid, the spongy hemostatic gelatin obtained by the above method has a drawback that it is dissolved by bleeding blood or body fluid infiltration when applied to a wound surface.
上記のゼラチンの溶解性の問題を解決するために、アル
デヒド類を作用させて、ゼラチン分子を架橋すると共に
発泡させ、ゼラチンの溶解を抑制する方法が提供されて
いる。しかし、この方法では、架橋剤の種類および量、
架橋の条件などによって、得られる変性ゼラチンの性質
に大きな差異があり、実用上満足できる性能のものを安
定して得ることはできない。In order to solve the above-mentioned problem of solubility of gelatin, there is provided a method in which an aldehyde is allowed to act to cross-link and foam gelatin molecules to suppress the dissolution of gelatin. However, in this method, the type and amount of cross-linking agent,
There is a large difference in the properties of the modified gelatin obtained depending on the crosslinking conditions and the like, and it is not possible to stably obtain the one having practically satisfactory performance.
[問題点を解決するための手段] 本発明は、架橋により溶解性が抑制されたゼラチンを使
用することにより、長期間優れた創傷治癒効果が維持さ
れる創傷カバー材に関する。[Means for Solving Problems] The present invention relates to a wound cover material that maintains excellent wound healing effect for a long period of time by using gelatin whose solubility is suppressed by crosslinking.
即ち、本発明は、ゼラチン5〜35重量%と水95〜65重量
%とからなる系に、ゼラチンに対して0.005〜5.0重量%
のラウリル硫酸ナトリウムおよびゼラチンに対して0.05
〜5m moleグリシジル基/gゼラチンのグリシジルエーテ
ル類を添加し、30〜60℃の温度範囲において混合撹拌し
て得られたゼラチン発泡体からなる創傷カバー材に関す
る。That is, the present invention relates to a system comprising 5 to 35% by weight of gelatin and 95 to 65% by weight of water, and 0.005 to 5.0% by weight of gelatin.
0.05 for sodium lauryl sulfate and gelatin
The present invention relates to a wound cover material composed of a gelatin foam obtained by adding glycidyl ethers of glycidyl group / g gelatin and mixing and stirring in the temperature range of 30 to 60 ° C.
本発明には、医用として用いられる一般的なゼラチン
が、そのまま利用可能である。それらのゼリー強度は、
100ブルーム以上、特に150〜300ブルームのものが好適
である。また、酸処理法およびアルカリ処理法の何れの
処理法によるゼラチンも利用可能であるが、アルカリ処
理法によるものの利用が好ましい。In the present invention, general gelatin used for medical purposes can be used as it is. Their jelly strength is
Those having 100 bloom or more, particularly 150 to 300 bloom are preferable. Gelatin prepared by any of the acid treatment method and the alkali treatment method can be used, but the alkali treatment method is preferably used.
グリシジルエーテル類としては、エチレンプロピレング
リコールジグリシジルエーテル、グリセロールポリグリ
シジルエーテル、ジグリセロールポリグリシジルエーテ
ル、ポリグリセロールポリグリシジルエーテル、ソルビ
トールポリグリシジルエーテル、エチレングリコールジ
グリシジルエーテルなどが挙げられる。エチレングリコ
ールジグリシジルエーテルが、安定した架橋が効率良く
得られるため好ましい。Examples of the glycidyl ethers include ethylene propylene glycol diglycidyl ether, glycerol polyglycidyl ether, diglycerol polyglycidyl ether, polyglycerol polyglycidyl ether, sorbitol polyglycidyl ether, and ethylene glycol diglycidyl ether. Ethylene glycol diglycidyl ether is preferable because stable crosslinking can be efficiently obtained.
次に、本発明の創傷カバー材の製造方法を説明する。Next, a method for manufacturing the wound cover material of the present invention will be described.
ゼラチンと水を5:95〜35:65の割合(重量%)で混合す
る。ゼラチンが5重量%未満では、発泡体の気孔径が極
めて不均一となり、また、発泡体が非常に柔らかいもの
となるため好ましくない。また、ゼラチンが35重量%を
越える場合は、発泡体の気孔が極めて微少なものとな
り、また、発泡体が非常に硬いものとなるため好ましく
ない。混合物を常温で4時間以上放置した後、30〜70
℃、好ましくは35〜45℃に加温し、緩やかに撹拌してゼ
ラチンを溶解する。引き続き加温状態を保ったままグリ
シジルエーテル類を添加し、次いで、ラウリル硫酸ナト
リウムを添加する。ラウリル硫酸ナトリウムはグリシジ
ルエーテル類と同時に添加してもよいし、数分後(2〜
5分後)に添加してもよい。グリシジルエーテル類の添
加量は0.05〜5m moleグリシジル基/gゼラチンの範囲が
好ましい。グリシジルエーテル類が0.05m moleグリシジ
ル基/gゼラチン未満であると、得られるゼラチン発泡体
の気孔の径が小さく、空隙率が低く、湿潤時の強度が極
めて小さい。グリシジルエーテル類の添加量が5m mole
グリシジル基/gゼラチンを越える場合は、得られるゼラ
チン発泡体の気孔の径のバラツキが大きく、また、硬度
が大きく創傷カバー材の創傷面への密着性が不良であ
る。混合物は通常撹拌して反応させる。撹拌に用いる槽
あるいは撹拌翼などは特に限定はされないが、撹拌効果
の大きい撹拌翼を用いて高速で撹拌することが好まし
い。反応時間は20秒間から5分間、特に30秒間〜2分間
であることが好ましい。反応時間が20秒未満では、架橋
が不十分であって、得られる創傷カバー材剤は容易に血
液、体液などに溶解し、安定した治癒効果が維持され得
ない。反応時間が5分を越える場合は、反応物の粘度が
増大し、発泡不足となって、創傷面への密着性が低下す
る。Gelatin and water are mixed at a ratio of 5:95 to 35:65 (% by weight). If the amount of gelatin is less than 5% by weight, the pore size of the foam becomes extremely uneven and the foam becomes very soft, which is not preferable. On the other hand, when the gelatin content exceeds 35% by weight, the pores of the foam become extremely small and the foam becomes extremely hard, which is not preferable. After leaving the mixture at room temperature for 4 hours or more, 30 ~ 70
C., preferably 35 to 45.degree. C., and gently stirred to dissolve gelatin. Subsequently, glycidyl ethers are added while keeping the heating state, and then sodium lauryl sulfate is added. Sodium lauryl sulfate may be added at the same time as the glycidyl ethers, or after a few minutes (2-
5 minutes later) may be added. The addition amount of glycidyl ethers is preferably in the range of 0.05 to 5 mmole glycidyl group / g gelatin. When the glycidyl ethers are less than 0.05m mole glycidyl group / g gelatin, the obtained gelatin foam has a small pore diameter, a low porosity, and an extremely low wet strength. Addition amount of glycidyl ethers is 5m mole
When it exceeds glycidyl groups / g gelatin, the obtained gelatin foam has a large variation in the pore diameter and the hardness is large, and the adhesion of the wound cover material to the wound surface is poor. The mixture is usually reacted by stirring. The tank or stirring blade used for stirring is not particularly limited, but it is preferable to perform stirring at high speed using a stirring blade having a large stirring effect. The reaction time is preferably 20 seconds to 5 minutes, particularly 30 seconds to 2 minutes. When the reaction time is less than 20 seconds, the crosslinking is insufficient, and the obtained wound covering material agent is easily dissolved in blood, body fluid, etc., and a stable healing effect cannot be maintained. If the reaction time exceeds 5 minutes, the viscosity of the reaction product increases, foaming becomes insufficient, and the adhesion to the wound surface decreases.
上記のようにして調製したゼラチン発泡体を、常法に従
って成型器に注入し、凍結乾燥することによって、本発
明の創傷カバー材が得られる。The wound foam material of the present invention is obtained by injecting the gelatin foam prepared as described above into a molding machine and freeze-drying it according to a conventional method.
本発明の創傷カバー材は、フィブロネクチン、リゾチー
ム、プラジオマイシン、ゲータマイシン、ポリミキシン
Bなどを添加吸収させるかあるいはこれらを担持させて
使用することもできる。The wound cover material of the present invention may be used by additionally absorbing fibronectin, lysozyme, prradiomycin, getamycin, polymyxin B, or by carrying these.
本発明の創傷カバー材は、フィルム状あるいはメッシュ
状の合成高分子材料層とからなる複合体として用いるこ
ともできる。複合体でない場合は、創傷部位に適宜の方
法により被着させ、他の材料、例えば、ガーゼなどで外
面を覆うことによって利用することができる。しかし、
本発明の創傷カバー材は、一般的には複合体として利用
するのが特に有利である。The wound cover material of the present invention can also be used as a composite comprising a film-shaped or mesh-shaped synthetic polymer material layer. When it is not a composite, it can be used by applying it to a wound site by an appropriate method and covering the outer surface with another material such as gauze. But,
The wound cover material of the present invention is particularly advantageous for use as a composite in general.
複合体の形成に用いられる合成高分子材料としては、創
傷面を覆い、適度の水蒸気透過性と酸素透過性、例え
ば、0.3〜1mg/cm2/hr程度の水分透過速度のものが利用
できる。また、外部からの細菌の浸入を防止する感染防
止効果を有するものであり、さらに、体液の流出防止効
果があればどのようなものでもよいが、比較的多孔性の
ポリエチレン、ポリプロピレンなどの合成高分子材料の
使用が好適であり、これらはフィルム状またはメッシュ
状として用いられる。As the synthetic polymer material used for forming the composite, a material that covers the wound surface and has appropriate water vapor permeability and oxygen permeability, for example, a water vapor transmission rate of about 0.3 to 1 mg / cm 2 / hr can be used. In addition, it has an infection-preventing effect that prevents the invasion of bacteria from the outside, and may be any as long as it has the effect of preventing the outflow of bodily fluids, but relatively high synthetic materials such as polyethylene and polypropylene Preference is given to using molecular materials, which are used as films or meshes.
以下に実施例によって本発明を詳細に説明する。The present invention will be described in detail below with reference to examples.
実施例1 ゼラチン発泡体の製造 ゼラチン(宮城化学(株)製E−170)7.5gに、蒸溜水5
0gを加えて室温で4時間放置後、40℃に加温し撹拌して
溶解した。次いで、架橋剤としてエチレングリコールジ
グリシジルエーテルを0.598g、発泡剤としてラウリル硫
酸ナトリウム0.25gを添加し、18500r.p.m.の回転速度で
1分間撹拌した。生成した発泡粘稠物を50×50×1mmの
大きさの成形器に素早く注入し、引き続き迅速に凍結乾
燥した。得られたゼラチン発泡体を37℃で24時間生理食
塩水に浸漬したが重量減少はみられず、溶出しないこと
が分かった。また、引張強度は11kg/cm2、引張伸びは12
%、曲げ弾性率は570kg/cm2であった。Example 1 Production of Gelatin Foam 7.5 g of gelatin (E-170 manufactured by Miyagi Chemical Co., Ltd.) was added to 5 g of distilled water.
After adding 0 g and leaving it at room temperature for 4 hours, it was heated to 40 ° C. and stirred to dissolve. Next, 0.598 g of ethylene glycol diglycidyl ether as a cross-linking agent and 0.25 g of sodium lauryl sulfate as a foaming agent were added, and the mixture was stirred at a rotation speed of 18500 rpm for 1 minute. The foamed viscous product produced was quickly poured into a 50 × 50 × 1 mm size molding machine and subsequently rapidly freeze-dried. It was found that the obtained gelatin foam was immersed in physiological saline at 37 ° C for 24 hours, but no weight loss was observed, and it did not elute. The tensile strength is 11 kg / cm 2 and the tensile elongation is 12
%, The flexural modulus was 570 kg / cm 2 .
このゼラチン発泡体を、厚さ50μ、平均孔径2.3μのポ
リエチレン製の多孔質フィルムの表面に100〜300μの厚
さに塗布し、創傷カバー材を製造した。The gelatin foam was applied to the surface of a polyethylene porous film having a thickness of 50 μm and an average pore diameter of 2.3 μm to a thickness of 100 to 300 μm to manufacture a wound cover material.
創傷治癒効果の評価(その1) Wister系雄ラット(9週令、体重300〜350g)の背部を
脱毛し、麻酔をし食後、デルマトームを用いて2.5×5cm
の創傷部を背部に作った、その創傷部位に実施例の創傷
カバー材を貼着し、3、7、10、14、17、21日後に創傷
面を観察すると共に、創傷カバー材そのものの変化を観
察した。結果を第1表に示す。Evaluation of Wound Healing Effect (1) Male Wister rats (9-week-old, weight 300-350 g) were depilated on the back, anesthetized and after eating, 2.5 × 5 cm using a dermatome
The wound cover of Example 1 was made on the back, the wound cover material of the example was attached to the wound site, and the wound surface was observed after 3, 7, 10, 14, 17, and 21 days, and the change of the wound cover material itself was observed. Was observed. The results are shown in Table 1.
創傷治癒効果の評価(その2) 先端が直径2cmのガラス棒を80℃の生理食塩水中に浸漬
し、ガラス棒自体の温度が80℃にまで昇温した後、取り
出して素早く上記のラットの脱毛した背部に10秒間押し
当てた。熱傷部位に発生した水泡を2時間後に剥離し、
この熱傷面に創傷カバー材を貼着し、上記と同様の観察
を行った。結果を第1表に示す。Evaluation of Wound Healing Effect (Part 2) A glass rod with a tip of 2 cm in diameter was immersed in physiological saline at 80 ° C, the temperature of the glass rod itself was raised to 80 ° C, and then taken out quickly to remove the hair from the rat. It was pressed against the back for 10 seconds. Peel off blisters generated at the burn site after 2 hours,
A wound cover material was attached to the burned surface, and the same observation as above was performed. The results are shown in Table 1.
実施例2 エチレングリコールジグリシジルエーテルを2.415g使用
した他は実施例1と同様にしてゼラチン発泡体を製造し
た。得られたゼラチン発泡体を37℃で24時間生理食塩水
に浸漬したが重量減少はみられず、溶出しないことが分
かった。また、引張強度は5.5kg/cm2、引張伸びは9.2
%、曲げ弾性率は284kg/cm2であった。このゼラチン発
泡体を使用して実施例1と同様にして創傷カバー材を得
た。得られた創傷カバー材を用いて実施例1と同様にし
て創傷治癒効果を評価した。結果を第1表に示す。Example 2 A gelatin foam was produced in the same manner as in Example 1 except that 2.415 g of ethylene glycol diglycidyl ether was used. It was found that the obtained gelatin foam was immersed in physiological saline at 37 ° C for 24 hours, but no weight loss was observed, and it did not elute. The tensile strength is 5.5 kg / cm 2 and the tensile elongation is 9.2.
%, The flexural modulus was 284 kg / cm 2 . A wound cover material was obtained in the same manner as in Example 1 using this gelatin foam. Using the obtained wound cover material, the wound healing effect was evaluated in the same manner as in Example 1. The results are shown in Table 1.
実施例3 ゼラチンとして宮城化学(株)製のE−290を使用した
他は実施例1と同様にしてゼラチン発泡体を製造した。
得られたゼラチン発泡体を37℃で24時間生理食塩水に浸
漬したが重量減少はみられず、溶出しないことが分かっ
た。また、引張強度は8.5kg/cm2、引張伸びは7.7%、曲
げ弾性率は762kg/cm2であった。このゼラチン発泡体を
使用して実施例1と同様にして創傷カバー材を得た。得
られた創傷カバー材を用いて実施例1と同様にして創傷
治癒効果を評価した。結果を第1表に示す。Example 3 A gelatin foam was produced in the same manner as in Example 1 except that E-290 manufactured by Miyagi Chemical Co., Ltd. was used as gelatin.
It was found that the obtained gelatin foam was immersed in physiological saline at 37 ° C for 24 hours, but no weight loss was observed, and it did not elute. The tensile strength was 8.5 kg / cm 2 , the tensile elongation was 7.7%, and the flexural modulus was 762 kg / cm 2 . A wound cover material was obtained in the same manner as in Example 1 using this gelatin foam. Using the obtained wound cover material, the wound healing effect was evaluated in the same manner as in Example 1. The results are shown in Table 1.
比較例 エチレングリコールジグリシジルエーテルを添加しなか
った以外は実施例と同様にしてゼラチン発泡体を製造し
た。得られたゼラチン発泡体を37℃で24時間生理食塩水
に浸漬したところ、ほとんど溶解してしまった。また、
引張強度は8.3kg/cm2、引張伸びは9.6%、曲げ弾性率は
590kg/cm2であった。このゼラチン発泡体を実施例1と
同様の多孔質フィルムに同程度の厚さに塗布し、創傷カ
バー材を製造した。Comparative Example A gelatin foam was produced in the same manner as in Example except that ethylene glycol diglycidyl ether was not added. When the obtained gelatin foam was immersed in physiological saline at 37 ° C. for 24 hours, it almost dissolved. Also,
Tensile strength is 8.3 kg / cm 2 , tensile elongation is 9.6%, flexural modulus is
It was 590 kg / cm 2 . This gelatin foam was applied to the same porous film as in Example 1 to a thickness of about the same to produce a wound cover material.
得られた創傷カバー材を用いて実施例1と同様にして創
傷治癒効果を評価した。結果を第1表に示す。Using the obtained wound cover material, the wound healing effect was evaluated in the same manner as in Example 1. The results are shown in Table 1.
なお、第1表には創傷治癒効果を比較するため、実施例
および比較例の評価結果の他に創傷の自然治癒の結果を
併せ記載した。In addition, in order to compare the wound healing effects, Table 1 also shows the results of the spontaneous healing of the wound in addition to the evaluation results of the examples and the comparative examples.
[発明の効果] 本発明の創傷カバー材は、適度に架橋され発泡されてお
り、創傷面への密着性が非常に優れていると共に、血液
あるいは体液などに溶解し難く、長期にわたって安定し
た創傷治癒効果が維持されるものである。[Effects of the Invention] The wound cover material of the present invention is appropriately crosslinked and foamed, has very excellent adhesion to the wound surface, is difficult to dissolve in blood or body fluid, and is a stable wound for a long period of time. The healing effect is maintained.
Claims (2)
からなる系に、ゼラチンに対して0.005〜5.0重量%のラ
ウリル硫酸ナトリウムおよびゼラチンに対して0.05〜5m
moleグリシジル基/gゼラチンのグリシジルエーテル類を
添加し、30〜60℃の温度範囲において混合撹拌して得ら
れたゼラチン発泡体からなる創傷カバー材。1. A system consisting of 5 to 35% by weight of gelatin and 95 to 65% by weight of water, 0.005 to 5.0% by weight of sodium lauryl sulfate and 0.05 to 5 m of gelatin.
A wound cover material consisting of a gelatin foam obtained by adding glycidyl ethers of glycidyl group / g gelatin and mixing and stirring in the temperature range of 30 to 60 ° C.
ルジグリシジルエーテルである特許請求の範囲第1項記
載の創傷カバー材。2. The wound cover material according to claim 1, wherein the glycidyl ethers are ethylene glycol diglycidyl ether.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61266570A JPH0728905B2 (en) | 1986-11-11 | 1986-11-11 | Wound cover material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61266570A JPH0728905B2 (en) | 1986-11-11 | 1986-11-11 | Wound cover material |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63164955A JPS63164955A (en) | 1988-07-08 |
| JPH0728905B2 true JPH0728905B2 (en) | 1995-04-05 |
Family
ID=17432654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61266570A Expired - Lifetime JPH0728905B2 (en) | 1986-11-11 | 1986-11-11 | Wound cover material |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0728905B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08131B2 (en) * | 1993-03-05 | 1996-01-10 | 新田ゼラチン株式会社 | Hemostasis pad |
-
1986
- 1986-11-11 JP JP61266570A patent/JPH0728905B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63164955A (en) | 1988-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6169123B1 (en) | Non-adherent nasal, sinus and otic packing and method for processing sponge materials in fabrication of packings | |
| JP2990239B2 (en) | Wound dressing material containing silk fibroin and silk sericin as main components and method for producing the same | |
| US6855743B1 (en) | Reinforced, laminated, impregnated, and composite-like materials as crosslinked polyvinyl alcohol hydrogel structures | |
| US4427808A (en) | Composite polymeric material for biological and medical applications and the method for its preparation | |
| US4552138A (en) | Dressing material based on a hydrogel, and a process for its production | |
| US6566576B1 (en) | Hydrocolloid foam medical dressings and method of making the same | |
| US3491760A (en) | Wound coverings | |
| JP2001520274A (en) | Foam material | |
| EP1265648B1 (en) | NOVEL collagen-BASED MATERIAL WITH IMPROVED PROPERTIES FOR USE IN HUMAN AND VETERINARY MEDICINE AND THE METHOD OF MANUFACTURING SUCH | |
| JPH06192383A (en) | Polyurethane foam manufacturing method | |
| JPS6317458B2 (en) | ||
| JP2003525083A (en) | Wound healing agent | |
| JPH09511168A (en) | Thermoplastic hydrogel impregnated composite material | |
| CN108853570A (en) | A kind of styptic sponge and preparation method thereof | |
| US20040105880A1 (en) | Interpenetrating polymer network | |
| JP5020639B2 (en) | Medicinal polyurethane foam | |
| CN108452366B (en) | A kind of cod skin gelatin composite hemostatic dressing and preparation method thereof | |
| JP2002511314A (en) | Polyurethane foam for use in wound dressings | |
| JP4044291B2 (en) | Water-swellable polymer gel and process for producing the same | |
| JPH0728905B2 (en) | Wound cover material | |
| JPH0728908B2 (en) | Wound cover material | |
| CN108892954B (en) | Tissue scaffold with double-layer structure and preparation method thereof | |
| KR102627866B1 (en) | Disposable medical material and manufacturing method thereof | |
| Zainol et al. | Effect of Dehydrothermal (Dht) Treatment on The Physicochemical Properties of 3D Porous Chitosan-Collagen-Glycerine Scaffold for Potential Skin Regenerating Template Applications | |
| JPH0728906B2 (en) | Medical materials |